Klinisk Biokemi i Norden Nr 4, vol. 30, 2018 - page 5

Roche Diagnostics Scandinavia AB, Box 1228, 171 23 Solna
TORCH: Toxoplasma Gondii, Other (Varicella Zoster Virus, Parvovirus B19, Enterovirus, and more), Rubella, Cytomegalovirus,
Herpes Simplex Virus; STDs: Sexually Transmitted Diseases (HIV, Hepatitis B, Syphilis);
Preeclampsia: PlGF 1st trimester, sFlt-1/PlGF 2-3 trimester
*Testing in neonates;
**Testing in mothers and neonates
References
1. Verlohren, S., Galindo, A., Schlemback, D., et al. (2010). Am J Obstet Gynecol 202 (161), e1-11.
2. National Institute for Health and Care excellence (NICE). (2014). Available at:https://www.nice.org.uk/guidance/cg62. Last accessed: 20 July 2015.
3. WHO RECOMMENDATIONS on Maternal Health GUIDELINES APPROVED BY THE WHO GUIDELINES REVIEW COMMITTEE Updated May 2017.
4. NICE guideline (2008) CG62https://www.nice.org.uk/guidance/CG62.
5. De Groot, L. et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline.
J. Clin. Endocrinol. Metab. 97, 2543–2565 (2012).
6. ACOG Committe Opinion no. 495https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Obstetric-Practice/
Vitamin-D-Screening-and-Supplementation-During-Pregnancy
Vitamin D
Thyroid
Anemia
TORCH
Preeclampsia
Down’s Syndrome & NIPT
STDs STDs STDs*
Thyroid**
TORCH*
2nd trimester 3rd trimester Postnatal
Recommended timeline for diagnostic testing during pregnancy1-6
1st trimester
Roche’s pregnancy care indiction
Broad spectrum of clinical testing with biomarkers